skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8129

Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients

Case report

(3134) Views  (948) Full article downloads

Authors: Dimitrios Brouzas, Antonios Charakidas, Ioannis Ladas, Michael Apostolopoulos

Published Date December 2008 Volume 2009:3 Pages 133 - 137
DOI: http://dx.doi.org/10.2147/OPTH.S4668

Dimitrios Brouzas, Antonios Charakidas, Ioannis Ladas, Michael Apostolopoulos

Department of Ophthalmology, University of Athens, Athens, Greece

Introduction: We report on three cases of visual loss due to nonarteritic anterior ischemic optic neuropathy that developed during the course of refractory anemia, a subtype of myelodysplastic syndrome.

Patients and methods: Patients underwent fundus, visual field examination, and fluorescein angiography. A thrombophilic tendency investigation including prothrombin time, partial thromboplastin time, protein C, free protein S, and antithrombin III, polymerase chain reaction and hybridisation to allele-specific oligonucleotide probes and a bone marrow biopsy were also performed.

Results: Relative recovery of visual function was noted in two patients, a 58-year-old man and a 67-year-old woman, whereas the vision of the third patient, a 62-year-old man, showed only marginal improvement during the follow-up period. Two patients received vigorous blood transfusion during hospitalization, while dosage adjustment of the erythropoietin infusion was decided for the third one. Thrombophilic tendency was not identified in any patient.

Discussion: Chronic anemia, as presented in myelodysplastic syndrome’s refractory anemia subtype, probably in the presence of additional factors, such as hypotension, is likely to be complicated by optic neuropathy, possibly through a mechanism of anemic hypoxia and/or microvascular insufficiency.

Keywords: myelodysplastic syndrome, anemia, optic neuropathy






 

Other articles by Professor D. Brouzas

Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin®) for AMD followed by controlateral sympathetic ophthalmia